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E-Cigarettes, Vaping, and Youth
The Family Smoking Prevention and Tobacco Control
Act of 2009 empowered the US Food and Drug
Administration (FDA) to regulate tobacco, the leading
preventable cause of death. The agency, however, initially exercised authority only over specific tobacco
products: cigarettes, cigarette tobacco, roll-your-own
(loose tobacco), and smokeless tobacco. This decision
left other forms of tobacco unregulated. Five years
later, in April 2014, the FDA sought to close this regulatory gap by issuing proposed rules—referred to as
“deeming”—to regulate electronic cigarettes, cigars,
pipe tobacco, nicotine gels, waterpipe (hookah)
tobacco, and orally ingested dissolvable tobacco products. The proposed rules represent a watershed
moment in tobacco control but do not go far enough in
regulating e-cigarettes, a product with uncertain benefits and potentially significant harms.
As their usage has increased substantially,
e-cigarettes have spurred enormous controversy. 1
E-cigarettes, which vary in power and potency, typically contain a nicotine-based liquid that is vaporized and

approval. Further, companies would be permitted to
make claims for reduced risk only if the agency confirms the claim based on scientific evidence while also
finding a benefit to the health of the public.
Although a vital step forward, the proposed rules
leave major issues unanswered, notably those regarding the use of flavored nicotine and marketing practices. By contrast, in February 2014, the European Union
issued a Tobacco Products Directive to safeguard youth,
including bans on advertising, promoting taste, and nicotine flavorings for e-cigarettes.2 Other countries, including Brazil, Lebanon, and Singapore, have banned
e-cigarettes entirely.
A lengthy rule-making process has compounded the
concerns associated with the proposed rules. Mired in
litigation, the FDA has been working since 2011 to extend its deeming authority, and it may be years before
the proposed rules are finalized. Even then, the FDA
plans to wait 2 years before enforcing warning labels and
requiring manufacturers to submit product applications. In the interim, new products will be permitted to
enter the market without preapproval,
while the popularity of youth “vaping,”
the colloquial term for e-cigarette use,
continues to increase.

The conundrum is how to regulate
e-cigarettes given scientific uncertainty
about the nature and extent of harms.
inhaled. Public health advocates have debated whether
e-cigarettes are effective harm reduction tools or offer
a pathway to smoking. By delivering nicotine and mimicking oral inhalation, e-cigarettes could reduce dependency on combustible cigarettes and prevent relapse.
Alternatively, e-cigarettes could become a gateway to
smoking by exposing young people to the world of nicotine and relegitimizing tobacco use in society. Probably
both scenarios are true: e-cigarettes can help older, entrenched smokers to quit smoking, whereas younger
nonsmokers could transition from electronic to combustible cigarettes once they are addicted to nicotine.
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As proposed, the FDA rules would set a federal minimum
age of 18 years to use e-cigarettes, require identification
to purchase them (currently, just more than half of states
imposeagerestrictions),prohibitmostsalesinvendingmachines,mandatewarninglabelsonpackaging,andprohibit
manufacturers from providing free samples.
Companies would be required to register
e-cigarettes with the FDA, submit safety data, and disclose product ingredients. FDA inspectors would monitor compliance. Companies would be able to introduce
new products to the market only after FDA review and

Balancing Benefits With Harms

Preliminary evidence demonstrates the
potential of e-cigarettes to reduce harm
by weaning smokers from combustible
tobacco, but the benefits appear minimal. At the same
time, evidence of harm is emerging. More powerful
e-cigarettes, commonly known as tank systems, heat
nicotine liquid hot enough to produce cancer-causing
carcinogens, such as formaldehyde and acetaldehyde,
in their vapor.3 Further, in a study of human bronchial
cells that contained some mutations found in smokers
at risk of lung cancer, scientists found a pattern of gene
expression in cells grown in a medium exposed to ecigarette vapor that was similar to the pattern found in
cells grown in a medium exposed to combustible tobacco smoke. 4 In addition, the virulence of drugresistant bacteria can be increased by e-cigarette vapors and affect the ability of cells to destroy bacteria.5
The Centers for Disease Control and Prevention reported an increase in calls to poison control centers after unintentional exposure of children to e-liquid, including oral ingestion, eye contact, and inhalation
exposure.6 Public reports commonly associated with
e-cigarettes include trouble breathing, headache, cough,
dizziness, sore throat, nose bleeds, chest pain, heart
palpitations,7 and allergic reactions such as itchiness and
lip swelling. The conundrum is how to regulate
e-cigarettes given scientific uncertainty about the nature and extent of harms.
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A New Youth Culture of Vaping
The increasing popularity of vaping has been associated with a surge
in nicotine use among adolescents. It took decades of social mobilization and political action to overcome the perception of smoking as
“cool,” even after the evidence became clear that smoking is deadly.
That intensive campaign—supported by smoke-free laws, advertising bans, and package warnings—could easily be reversed by the popularity of vaping. Even though today’s youth grew up inculcated with
negative social stigma around the use of combustible cigarettes, vaping products are often marketed as highly palatable and accessible alternatives. In recent years, tobacco companies such as Altria as well
as niche manufacturers like NJoy have aggressively entered this market by reinventing brand appeal and normalizing vaping.
With the decline in recent years in the prevalence of young tobacco smokers—the most profitable long-term consumers—it is no
surprise that youth are a key demographic of the vaping campaign.
Colorful advertisements touting flavors such as bubble gum or with
celebrity actors conjure images of Joe Camel and the Marlboro Man.
The industry skirts accusations of deliberately catering to youthful
consumers by asserting that e-cigarettes are a safer alternative to
combustible cigarettes or positioning e-cigarettes as nicotine replacement therapies.8
The Centers for Disease Control and Prevention reported that
between 2011 and 2012, the proportion of high school students who
had tried e-cigarettes doubled from 4.7% to 10%.9 Although alarming, this figure significantly underestimates the proliferation of nicotine intake by vaping among adolescents. The study directly addressed e-cigarettes but left out a related class of devices that also
create a nicotine vapor: e-hookahs, hookah pens, and vape pipes.
The failure of adolescents to equate vaping products generally
with e-cigarettes underscores how successful the tobacco industry has been in reinventing a popular “smoking” trend. The FDA emARTICLE INFORMATION

Important Next Steps
The oral satisfaction of e-cigarettes, together with their ability to deliver nicotine without combusting tobacco, poses a double-edged
sword for public health. Although it will be easier to replace one highly
dangerous addiction (cigarettes) with a seemingly less dangerous
alternative (e-cigarettes), the same dynamics may recruit many
young people, addicting them to nicotine, with some transitioning
to combustible tobacco. There is also a major risk that e-cigarettes
will revive the popular smoking culture that has taken decades to
dismantle.
The FDA deeming proposal offers the welcome promise of a
regulatory structure to ensure that e-cigarettes and other vaping
products are safe and effective. However, the agency should move
boldly and rapidly to prevent companies from exploiting youth. By
bolstering the proposed rules to limit advertising and prohibit flavored nicotine, the agency could prevent proliferation of e-cigarette
use among adolescents, while not undermining its regulatory goal
of reducing harm. Before the comment period on the proposed rules
closes in July, the public health community should speak with a clear
voice to urge meaningful and effective regulation to protect US youth
against the reinvention of Big Tobacco.
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